Global Diabetic Nephropathy Market Research and Forecast 2018-2023

  • ID: 4585981
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Dec 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma, Inc.
  • Cellmid Ltd.
  • Dong Wha Pharma Co., Ltd.
  • Genkyotex.Com
  • Glucox Biotech
  • MORE
Diabetic nephropathy is a clinical syndrome related to damage or impairment of kidney and majorly affects type-1 and type-2 diabetic patients. It can cause severe complications in the kidney such as macroalbuminuria, in which more than 300mg of urinary albumin is excreted by the kidney in the period of 24-hours. Diabetic nephropathy market is one of the major causes for the occurrence of chronic kidney diseases and renal failure across the globe.

Major factors contributing to the growth of the global diabetic nephropathy market include increasing prevalence of diabetic patients across the globe due to sedentary lifestyle and faulty dietary habits of the population across the globe. Initiatives taken by the government by rising spending on the development of advanced technologies for the treatment of the disease and increasing demand for home-based diagnostic technologies are fueling the market growth. Stringent regulatory policies for the approval of diabetic nephropathy drugs and increasing number of patent expirations are some of the factors hindering the growth of the market. Some of the other factors responsible for restraining market growth are the high cost of imaging devices and long duration of clinical trials. However, the advancements in diagnostic imaging technology is expected to propel the market growth in the near future.

The diabetic nephropathy market can be segmented on the basis of indication, diagnosis type, treatment type, and end user. Based on indication, the market is segmented into diabetes type-1 and diabetes type-2. Based on diagnosis type, the market is bifurcated into urine test, imaging tests, blood test, renal function testing, and renal biopsy. Based on treatment type, the market is segmented into medications, kidney dialysis, kidney transplant, and acupuncture. Medications can be further segmented into diuretics, angiotensin-converting enzyme inhibitors, antioxidant inflammation modulator, angiotensin receptor blockers, renin inhibitors, calcium channel blockers, and others (monocyte chemoattractant proteins inhibitor and g protein-coupled receptors). Based on end user, the market is diversified into hospital & clinic, diagnostic center, and research institutes. Among type of treatments, the medications segment holds a major share in the diabetic nephropathy market. This is owing to wide availability of drugs for specific symptoms related to diabetic nephropathy.

The global diabetic nephropathy market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global diabetic nephropathy market, followed by Europe. This is mainly owing to rising awareness amongst the population about the various kidney-related diseases. High reimbursement policies by the government in the healthcare sector and demand for continuous monitoring of diabetes are some factors that are significantly contributing towards the market growth in the region. In Europe, the growing demand for home-based diagnosis of the disease, especially among the geriatric population is one of the major factors fuelling the market growth. Asia Pacific is projected to exhibit fastest growth in the global diabetic nephropathy market over the forecast period. This is due to large pool of diabetic population in the region, especially in Japan and Southeast Asian countries.

Some of the key players operating in the global diabetic nephropathy market are Abbott Laboratories, Bayer AG, AstraZeneca, Xortx Therapeutics Inc., Glaxosmithkline plc, Astellas Pharma, Inc., and AbbVie Inc., among others. In order to sustain in the competitive market, these players adopt various strategies such as Acquisitions, mergers, expansions, joint ventures and product development and so on.

Research Methodology:

The market study of diabetic nephropathy market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic public databases such as NIH NIDDK, American Journal of Kidney Diseases, Centers for Disease Control and Prevention (CDC), and others
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalogue.
  • Supplier Websites such as Alibaba, amazon for pricing analysis.
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

Market Segmentation:

Global diabetic nephropathy market is segmented on the basis of regional outlook and following segments:

1. Global Diabetic Nephropathy Market Research and Analysis, By Indication
2. Global Diabetic Nephropathy Market Research and Analysis, By Diagnosis Type
3. Global Diabetic Nephropathy Market Research and Analysis, By Treatment Type
4. Global Diabetic Nephropathy Market Research and Analysis, By End User
5. Global Diabetic Nephropathy Market Research and Analysis, By Region

The Report Covers
  • Comprehensive research methodology of global diabetic nephropathy market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global diabetic nephropathy market.
  • Insights about market determinants which are stimulating the global diabetic nephropathy market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma, Inc.
  • Cellmid Ltd.
  • Dong Wha Pharma Co., Ltd.
  • Genkyotex.Com
  • Glucox Biotech
  • MORE
Chapter 1. Report Summary
1.1. Research Methods And Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

Chapter 2. Market Overview And Insights
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1.1. United States
2.3.1.2. European Union
2.3.1.3. China
2.3.1.4. India

Chapter 3. Market Determinant
3.1. Motivators
3.1.1. Increasing Prevalence Of Diabetes
3.1.2. Increasing Demand For Home Diagnosis
3.1.3. Rising Funds For R&D Due To Increasing Number Of Kidney-Related Diseases
3.2. Restraints
3.2.1. Stringent Regulatory Policies For The Approval Of Drugs
3.2.2. Long Duration Of Clinical Trials
3.2.3. Increasing Number Of Patent Expirations
3.2.4. High Cost Of Imaging Devices
3.3. Opportunities
3.3.1. Increasing Awareness Of Diabetic Nephropathy Drugs
3.3.2. Technological Advancements In Diagnostic Imaging

Chapter 4. Market Segmentation
4.1. Global Diabetic Nephropathy Market, By Indication
4.1.1. Diabetes Type-1
4.1.2. Diabetes Type-2
4.2. Global Diabetic Nephropathy Market, By Diagnosis Type
4.2.1. Urine Test
4.2.2. Imaging Tests
4.2.3. Blood Test
4.2.4. Renal Function Testing
4.2.5. Renal Biopsy
4.3. Global Diabetic Nephropathy Market, By Treatment Type
4.3.1. Medications
4.3.1.1. Diuretics
4.3.1.2. Angiotensin-Converting Enzyme Inhibitors
4.3.1.3. Antioxidant Inflammation Modulator
4.3.1.4. Angiotensin Receptor Blockers
4.3.1.5. Renin Inhibitors
4.3.1.6. Calcium Channel Blockers
4.3.1.7. Others (Monocyte Chemoattractant Proteins Inhibitor And G Protein-Coupled Receptors)
4.3.2. Kidney Dialysis
4.3.3. Kidney Transplant
4.3.4. Acupuncture
4.4. Global Diabetic Nephropathy Market By End User
4.4.1. Hospital & Clinic
4.4.2. Diagnostic Center
4.4.3. Research Institutes

Chapter 5. Competitive Landscape
5.1. Key Company Analysis
5.2. Key Strategy Analysis

Chapter 6. Regional Analysis
6.1. North American
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. U.K
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Roe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Roapac
6.4. Rest Of The World

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.2. Abbvie Inc.
7.3. Aerpio
7.4. Antisense Therapeutics Limited
7.5. Astellas Pharma, Inc.
7.6. Astrazeneca
7.7. Bayer Ag
7.8. Bristol-Myers Squibb Company
7.9. Cellmid Ltd.
7.10. Chemocentryx, Inc.
7.11. Concert Pharmaceuticals, Inc.
7.12. Daiichi Sankyo Company, Limited.
7.13. Diamedica Therapeutics, Inc.
7.14. Dimerix
7.15. Dong Wha Pharma Co., Ltd.
7.16. Eli Lilly And Company
7.17. Evotec Ag
7.18. Galectin Therapeutics Inc.
7.19. Genkyotex.Com
7.20. Gilead
7.21. Glaxosmithkline Plc.
7.22. Glucox Biotech
7.23. Gni Group Ltd.
7.24. Intercept Pharmaceuticals, Inc.
7.25. Inventiva Pharma
7.26. Jenrin Discovery
7.27. Johnson & Johnson Services, Inc.
7.28. Mesoblast Ltd
7.29. Mitsubishi Tanabe Pharma Europe Ltd
7.30. Noxxon Pharma
7.31. Xortx Therapeutics Inc.

List Of Tables
Table # 1 Global Diabetic Nephropathy Market Research And Analysis By Indication, 2017-2023 ($ Million)
Table # 2 Global Diabetes Type-1 Market Research And Analysis, 2017-2023 ($ Million)
Table # 3 Global Diabetes Type-2 Market Research And Analysis, 2017-2023 ($ Million)
Table # 4 Global Diabetic Nephropathy Market Research And Analysis By Diagnosis Type, 2017-2023 ($ Million)
Table # 5 Global Urine Test Market Research And Analysis, 2017-2023 ($ Million)
Table # 6 Global Imaging Test Market Research And Analysis, 2017-2023 ($ Million)
Table # 7 Global Blood Test Market Research And Analysis, 2017-2023 ($ Million)
Table # 8 Global Renal Function Testing Market Research And Analysis, 2017-2023 ($ Million)
Table # 9 Global Renal Biopsy Market Research And Analysis, 2017-2023 ($ Million)
Table # 10 Global Diabetic Nephropathy Market Research And Analysis By Treatment Type, 2017-2023 ($ Million)
Table # 11 Global Medications Market Research And Analysis, 2017-2023 ($ Million)
Table # 12 Global Diuretics Market Research And Analysis, 2017-2023 ($ Million)
Table # 13 Global Angiotensin-Converting Enzyme Inhibitors Market Research And Analysis, 2017-2023 ($ Million)
Table # 14 Global Antioxidant Inflammation Modulator Market Research And Analysis, 2017-2023 ($ Million)
Table # 15 Global Angiotensin Receptor Blockers Market Research And Analysis, 2017-2023 ($ Million)
Table # 16 Global Renin Inhibitors Market Research And Analysis, 2017-2023 ($ Million)
Table # 17 Global Calcium Channel Blockers Market Research And Analysis, 2017-2023 ($ Million)
Table # 18 Global Others Market Research And Analysis, 2017-2023 ($ Million)
Table # 19 Global Kidney Dialysis Market Research And Analysis, 2017-2023 ($ Million)
Table # 20 Global Kidney Transplant Market Research And Analysis, 2017-2023 ($ Million)
Table # 21 Global Acupuncture Market Research And Analysis, 2017-2023 ($ Million)
Table # 22 Global Diabetic Nephropathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 23 Global Hospital & Clinic Market Research And Analysis, 2017-2023 ($ Million)
Table # 24 Global Diagnostic Center Market Research And Analysis, 2017-2023 ($ Million)
Table # 25 Global Research Institutes Market Research And Analysis, 2017-2023 ($ Million)
Table # 26 Global Diabetic Nephropathy Market Research And Analysis By Geography, 2017-2023 ($ Million)
Table # 27 North American Diabetic Nephropathy Market Research And Analysis By Country, 2017-2023 ($ Million)
Table # 28 North American Diabetic Nephropathy Market Research And Analysis By Indication, 2017-2023 ($ Million)
Table # 29 North American Diabetic Nephropathy Market Research And Analysis By Diagnosis Type, 2017-2023 ($ Million)
Table # 30 North American Diabetic Nephropathy Market Research And Analysis By Treatment Type, 2017-2023 ($ Million)
Table # 31 North American Diabetic Nephropathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 32 European Diabetic Nephropathy Market Research And Analysis By Country, 2017-2023 ($ Million)
Table # 33 European Diabetic Nephropathy Market Research And Analysis By Indication, 2017-2023 ($ Million)
Table # 34 European Diabetic Nephropathy Market Research And Analysis By Diagnosis Type, 2017-2023 ($ Million)
Table # 35 European Diabetic Nephropathy Market Research And Analysis By Treatment Type, 2017-2023 ($ Million)
Table # 36 European Diabetic Nephropathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 37 Apac Diabetic Nephropathy Market Research And Analysis By Country, 2017-2023 ($ Million)
Table # 38 Apac Diabetic Nephropathy Market Research And Analysis By Indication, 2017-2023 ($ Million)
Table # 39 Apac Diabetic Nephropathy Market Research And Analysis By Diagnosis Type, 2017-2023 ($ Million)
Table # 40 Apac Diabetic Nephropathy Market Research And Analysis By Treatment Type, 2017-2023 ($ Million)
Table # 41 Apac Diabetic Nephropathy Market Research And Analysis By End User, 2017-2023 ($ Million)
Table # 42 Row Diabetic Nephropathy Market Research And Analysis By Indication, 2017-2023 ($ Million)
Table # 43 Row Diabetic Nephropathy Market Research And Analysis By Diagnosis Type, 2017-2023 ($ Million)
Table # 44 Row Diabetic Nephropathy Market Research And Analysis By Treatment Type, 2017-2023 ($ Million)
Table # 45 Row Diabetic Nephropathy Market Research And Analysis By End User, 2017-2023 ($ Million)

List Of Figures
Figure # 1 Global Diabetic Nephropathy Market Share By Indication, 2017 Vs 2023 (%)
Figure # 2 Global Diabetic Nephropathy Market Share By Diagnosis Type, 2017 Vs 2023 (%)
Figure # 3 Global Diabetic Nephropathy Market Share By Treatment Type, 2017 Vs 2023 (%)
Figure # 4 Global Diabetic Nephropathy Market Share By End User, 2017 Vs 2023 (%)
Figure # 5 Us Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 6 Canada Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 7 Uk Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 8 France Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 9 Germany Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 10 Italy Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 11 Spain Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 12 Roe Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 13 India Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 14 China Diabetic Nephropathy Marketsize, 2017-2023 ($ Million)
Figure # 15 Japan Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 16 Roapac Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Figure # 17 Rest Of The World Diabetic Nephropathy Market Size, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Abbvie Inc.
  • Aerpio
  • Antisense Therapeutics Limited
  • Astellas Pharma, Inc.
  • Astrazeneca
  • Bayer Ag
  • Bristol-Myers Squibb Company
  • Cellmid Ltd.
  • Chemocentryx, Inc.
  • Concert Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Limited.
  • Diamedica Therapeutics, Inc.
  • Dimerix
  • Dong Wha Pharma Co., Ltd.
  • Eli Lilly And Company
  • Evotec Ag
  • Galectin Therapeutics Inc.
  • Genkyotex.Com
  • Gilead
  • Glaxosmithkline Plc.
  • Glucox Biotech
  • Gni Group Ltd.
  • Intercept Pharmaceuticals, Inc.
  • Inventiva Pharma
  • Jenrin Discovery
  • Johnson & Johnson Services, Inc.
  • Mesoblast Ltd
  • Mitsubishi Tanabe Pharma Europe Ltd
  • Noxxon Pharma
  • Xortx Therapeutics Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll